Linatin D 10mg/5mg Tablet

The combination offers complementary mechanisms to improve glycemic control in patients inadequately controlled by diet and exercise alone or in combination with other antidiabetic agents. Linatin D is administered orally once daily, with or without food. It is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe renal impairment, or hypersensitivity to its components.

Common adverse effects include urinary tract infections, nasopharyngitis, and hypoglycemia when used with insulin or insulin secretagogues. Regular monitoring of renal function, blood glucose, and signs of volume depletion is recommended during therapy. Linatin D should be used as part of a comprehensive diabetes management plan including diet, exercise, and regular monitoring to achieve optimal glycemic control and reduce the risk of diabetes-related complications.